Baron, F <br/><br/>
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.  [electronic resource] 

 -  Leukemia  May 2005 
 - 822-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2403718  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antigens, CD34--analysis<br/>Child<br/>Child, Preschool<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Graft Rejection--prevention & control<br/>Graft Survival<br/>Graft vs Host Disease--prevention & control<br/>Hematologic Neoplasms--therapy<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Reproducibility of Results<br/>Risk Factors<br/>Survival Analysis<br/>T-Lymphocytes--drug effects<br/>Transplantation Chimera--immunology<br/>Transplantation Conditioning--methods